Cardiovascular effects of isradipine in essential hypertension
- 1 July 1991
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 68 (1) , 65-70
- https://doi.org/10.1016/0002-9149(91)90712-t
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Evaluation of isradipine (PN 200-110) in mild to moderate hypertensionClinical Pharmacology & Therapeutics, 1987
- Treatment of essential hypertension with PN 200-110 (isradipine)The American Journal of Cardiology, 1987
- Efficacy of a new calcium antagonist PN 200-110 (Isradipine) in angina pectorisThe American Journal of Cardiology, 1987
- Hemodynamic effects of PN 200-110 (isradipine) in congestive heart failureThe American Journal of Cardiology, 1987
- Comparison of cardiodepressant and vasodilator effects of PN 200-110 (isradipine), nifedipine and diltiazem in anesthetized rabbitsThe American Journal of Cardiology, 1987
- Selective effects of PN 200-110 (isradipine) on the peripheral circulation and the heartThe American Journal of Cardiology, 1987
- Separation of the Coronary Vasodilator from the Cardiac Effects of PN 200–110, a New Dihydropyridine Calcium Antagonist, in the Dog HeartJournal of Cardiovascular Pharmacology, 1985
- PN 200–110, A New Calcium AntagonistJournal of Cardiovascular Pharmacology, 1984
- Safety, tolerability and efficacy of PN 200-110, a new calcium antagonist in patients with angina and coronary heart diseaseEuropean Journal of Clinical Pharmacology, 1984
- Systemic and regional hemodynamics in low, normal and high cardiac output borderline hypertension.Circulation, 1978